Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Search
FDAReview.org
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Raymond March
43 POSTS
0 COMMENTS
Raymond J. March
is a Research Fellow at the Independent Institute and Assistant Professor of Economics at North Dakota State University.
All Blog Posts
|
Full bio and publications
FDA Struggles to Develop “Sugar Added” Labels for Honey and Maple...
Raymond March
-
September 26, 2018
0
Let Competition, Not the FDA, Resolve the EpiPen Shortage
Raymond March
-
September 12, 2018
0
Government vs. Private Efforts to Promote Breastfeeding: My Response to a...
Raymond March
-
September 2, 2018
0
FDA Considers Regulating E-cigarette Juices
Raymond March
-
September 1, 2018
0
FDA Approves Medical App for Contraception
Raymond March
-
August 22, 2018
0
Open Up Off-Label Drug Communication and Let the Market Work!
Raymond March
-
August 7, 2018
0
Three Reasons To Be Optimistic about Pharmaceutical Policy
Raymond March
-
August 2, 2018
0
If Telemedicine Is Underachieving, Government Is to Blame
Raymond March
-
July 11, 2018
0
Misdiagnosing Right-to-try Laws
Raymond March
-
July 6, 2018
0
Putting Right-to-Try Drug Prices in Perspective
Raymond March
-
July 2, 2018
0
1
2
3
4
5
Page 3 of 5
Edit with Live CSS
